These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2379535)

  • 1. Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis.
    Geisslinger G; Schuster O; Stock KP; Loew D; Bach GL; Brune K
    Eur J Clin Pharmacol; 1990; 38(5):493-7. PubMed ID: 2379535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and bioinversion of ibuprofen enantiomers in humans.
    Cheng H; Rogers JD; Demetriades JL; Holland SD; Seibold JR; Depuy E
    Pharm Res; 1994 Jun; 11(6):824-30. PubMed ID: 7937520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
    Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in the stereoselective disposition of ibuprofen in patients with rheumatoid arthritis.
    Geisslinger G; Stock KP; Loew D; Bach GL; Brune K
    Br J Clin Pharmacol; 1993 Jun; 35(6):603-7. PubMed ID: 8329287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans.
    Evans AM; Nation RL; Sansom LN; Bochner F; Somogyi AA
    Biopharm Drug Dispos; 1990; 11(6):507-18. PubMed ID: 2207301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interindividual variability in the enantiomeric disposition of ibuprofen following the oral administration of the racemic drug to healthy volunteers.
    Avgerinos A; Hutt AJ
    Chirality; 1990; 2(4):249-56. PubMed ID: 2083147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ibuprofen enantiomers after single and repeated doses in man.
    Oliary J; Tod M; Nicolas P; Petitjean O; Caillé G
    Biopharm Drug Dispos; 1992 Jul; 13(5):337-44. PubMed ID: 1498267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of food or sucralfate on the bioavailability of S(+) and R(-) enantiomers of ibuprofen.
    Levine MA; Walker SE; Paton TW
    J Clin Pharmacol; 1992 Dec; 32(12):1110-4. PubMed ID: 1487549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ibuprofen enantiomers in dogs.
    Beck WS; Geisslinger G; Engler H; Brune K
    Chirality; 1991; 3(3):165-9. PubMed ID: 1911048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in the disposition of ibuprofen enantiomers in osteoarthritis patients.
    Rudy AC; Bradley JD; Ryan SI; Kalasinski LA; Xiaotao Q; Hall SD
    Ther Drug Monit; 1992 Dec; 14(6):464-70. PubMed ID: 1485367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-ibuprofen versus ibuprofen-racemate. A randomized double-blind study in patients with rheumatoid arthritis.
    Stock KP; Geisslinger G; Loew D; Beck WS; Bach GL; Brune K
    Rheumatol Int; 1991; 11(4-5):199-202. PubMed ID: 1784888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen.
    Tornio A; Niemi M; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2007 May; 63(5):463-9. PubMed ID: 17333159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates.
    Jamali F; Singh NN; Pasutto FM; Russell AS; Coutts RT
    Pharm Res; 1988 Jan; 5(1):40-3. PubMed ID: 3244607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of presystemic inversion of (R)- to (S)-ibuprofen in humans.
    Hall SD; Rudy AC; Knight PM; Brater DC
    Clin Pharmacol Ther; 1993 Apr; 53(4):393-400. PubMed ID: 8477555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen lysinate, quicker and less variable: relative bioavailability compared to ibuprofen base in a pediatric suspension dosage form.
    Ferrero-Cafiero JM; Gich I; Puntes M; Martínez J; Ballester MR; Coimbra J; Mathison Y; Tarré M; Font X; Antonijoan RM
    Int J Clin Pharmacol Ther; 2015 Nov; 53(11):972-9. PubMed ID: 26249766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate.
    Lötsch J; Muth-Selbach U; Tegeder I; Brune K; Geisslinger G
    Br J Clin Pharmacol; 2001 Oct; 52(4):387-98. PubMed ID: 11678782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen in humans.
    Knights KM; McLean CF; Tonkin AL; Miners JO
    Br J Clin Pharmacol; 1995 Aug; 40(2):153-6. PubMed ID: 8562298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the bioavailability of dexibuprofen administered alone or as part of racemic ibuprofen.
    Gabard B; Nirnberger G; Schiel H; Mascher H; Kikuta C; Mayer JM
    Eur J Clin Pharmacol; 1995; 48(6):505-11. PubMed ID: 8582471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and Bioavailability of a Fixed-Dose Combination of Ibuprofen and Paracetamol after Intravenous and Oral Administration.
    Atkinson HC; Stanescu I; Frampton C; Salem II; Beasley CP; Robson R
    Clin Drug Investig; 2015 Oct; 35(10):625-32. PubMed ID: 26334726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.